Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
4,018
+1
+0% +$91 0.3% 49
2026
Q1
$413K Sell
4,017
-1
-0% -$113 0.38% 45
2025
Q4
$503K Buy
4,018
+18
+0.5% +$2.29K 0.51% 39
2025
Q3
$536K Buy
+4,000
New +$525K 0.54% 38

Other funds holding ABT

Payne Capital's ABT Position: Q2 2026 in Review

Payne Capital increased its Abbott (ABT) stake by 0.02% in Q2 2026, buying an estimated $91 and bringing the position to 4,018 shares worth $365K. The position accounts for 0.3% of the portfolio, ranked #49.

Payne Capital first reported a position in ABT in Q3 2025 and has held it in 4 quarters since. The position peaked at $536K in Q3 2025. 2,935 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Payne Capital held 4,018 shares of Abbott worth $365K as of Q2 2026.
  • Payne Capital bought 1 Abbott share in Q2 2026, an estimated $91.
  • Abbott made up 0.3% of Payne Capital's portfolio in Q2 2026, its #49 holding.
  • Payne Capital first reported a position in Abbott in Q3 2025 and has held it in 4 quarters since.
  • Payne Capital's Abbott position peaked at $536K in Q3 2025.
  • 2,935 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Payne Capital's 13F filing for Q2 2026, filed 11 Aug 2026.